Paxman AB
Develops scalp cooling systems to minimize hair loss for cancer patients.
PAX | ST
Overview
Corporate Details
- ISIN(s):
- SE0009806284
- LEI:
- 549300OT2V7Q4IDX8X68
- Country:
- Sweden
- Address:
- Pirgatan 13, 374 35 Karlshamn
- Website:
- https://paxman.se/
- Sector:
- Manufacturing
Description
Paxman AB is a global leader in medical technology focused on chemotherapy side effect management. The company develops and supplies the PAXMAN Scalp Cooling System, a cryotherapy-based treatment designed to minimize hair loss (alopecia) for cancer patients undergoing cytostatic treatments. With a mission to improve the quality of life for patients, Paxman's technology is used in hospitals, clinics, and treatment centers worldwide. The company has installed thousands of systems in over 65 countries, supporting more than 100,000 patients. In 2025, Paxman announced a merger with Dignitana, another key provider of scalp cooling technology, to further strengthen its market position.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Paxman AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Paxman AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Paxman AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-12-05 | Glenn Paxman | Other | Sell | 1,403,069 | 91,199,485.00 SEK |
Peer Companies
